Perceptive Advisors LLC Fibrogen Inc Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $326,919 - $516,762	-9,306 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $398,575 - $557,522	9,306 New	9,306 $506,000
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $360,476 - $516,439	-8,593 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $287,006 - $463,162	8,593	8,593 $462,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.